Insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Alzheimer's disease

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 12, 2012, Pages 4673-4681

  Duron, Emmanuelle ^a,b,c   Funalot, Benoît ^c   Brunel, Nadège ^d   Coste, Joel ^e   Quinquis, Laurent ⁱ   Viollet, Cécile ^c   Belmin, Joel ^f   Jouanny, Pierre ^g   Pasquier, Florence ^h   Treluyer, Jean Marc ^g,j   Epelbaum, Jacques ^c   Le Bouc, Yvesle ^d   Hanon, Olivier ^a,b  

^a Paris Descartes University   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSERM   (France)

^d HÔPITAL SAINT ANTOINE   (France)

^e HÔTEL DIEU   (France)

^f HÔPITAL CHARLES FOIX   (France)

^g AMIENS UNIVERSITY HOSPITAL   (France)

^h UNIV LILLE   (France)

ⁱ Paris Descartes University   (France)

^j ACTION Study Group   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

AGE; AGED; ALZHEIMER DISEASE; APOE EPSILON 4 GENE; ARTICLE; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; EDUCATIONAL STATUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MILD COGNITIVE IMPAIRMENT; PRIORITY JOURNAL; SEX DIFFERENCE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEINS E; COGNITION; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MEMORY; NEUROPSYCHOLOGICAL TESTS;

EID: 84870742983     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-2063     Document Type: Article

References (47)

1. Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E 2011 Alzheimer's disease. Lancet 377:1019-1031
2. Holzenberger M, Dupont J, Ducos B, Leneuve P, Géloën A, Even PC, Cervera P, Le Bouc Y 2003 IGF-I receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421:182-187
3. Fernandez AM, Torres-Alemán I 2012 The many faces of insulinlike peptide signalling in the brain. Nat Rev Neurosci 13:225-239
4. Carro E, Trejo JL, Gomez-Isla T, LeRoith D, Torres-Aleman I 2002 Serum insulin-like growth factor I regulates brain amyloid-β levels. Nat Med 8:1390-1397 (Pubitemid 36019424)
5. Hong M, Lee VM 1997 Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. J Biol Chem 272:19547-19553 (Pubitemid 27337756)
6. Froesch ER, Hussain MA, Schmid C, Zapf J 1996 Insulin-like growth factor I: physiology, metabolic effects and clinical uses. Diabetes Metab Rev 12:195-215 (Pubitemid 26401266)
7. Aleman A, Torres-Alemán I 2009 Circulating insulin-like growth factor I and cognitive function: neuromodulation throughout the lifespan. Prog Neurobiol 89:256-265
8. Watanabe T, Miyazaki A, Katagiri T, Yamamoto H, Idei T, Iguchi T 2005 Relationship between serum insulin-like growth factor-1 levels and Alzheimer's disease and vascular dementia. J Am Geriatr Soc 53:1748-1753 (Pubitemid 43109939)
9. Vardy ER, Rice PJ, Bowie PC, Holmes JD, Grant PJ, Hooper NM 2007 Increased circulating insulin-like growth factor-1 in late-onset Alzheimer's disease. J Alzheimers Dis 12:285-290
10. Vargas T, Martinez-Garcia A, Antequera D, Vilella E, Clarimon J, Mateo I, Sanchez-Juan P, Rodriguez-Rodriguez E, Frank A, Rosich-Estrago M, Lleo A, Molina-Porcel L, Blesa R, Gomez-Isla T, Combarros O, Bermejo-Pareja F, Valdivieso F, Bullido MJ, Carro E 2011 IGF-I gene variability is associated with an increased risk for AD. Neurobiol Aging 32:556.e3-.e11
11. Folstein MF, Folstein SE, McHugh PR 1975 Mini-mental state. A practical method for grading the cognitive. J Psychiatr Res 12:189-198
12. De Rotrou J, Forette F, Hervy MP, Tortra D, Fermanian J, Boudou MR, Boller F 1991 The cognitive efficiency profile: description and validation in patients with Alzheimer's disease. Int J Geriatr Psychiatry 6:501-509
13. Lawton MP, Brody EM 1969 Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9:179-186
14. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW 1963 Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 185:914-919
15. Wilson HS, Skodol A 1994 Special report. DSM-IV: overview and examination of major changes. Arch Psychiatr Nurs 8:340-347
16. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM 1984 Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34:939-944 (Pubitemid 14076461)
17. Portet F, Ousset PJ, Visser PJ, Frisoni GB, Nobili F, Scheltens P, Vellas B, Touchon J; MCI Working Group of the European Consortium on Alzheimer's Disease (EADC) 2006 Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure report of the MCI Working Group of the European Consortium on Alzheimer's Disease. J Neurol Neurosurg Psychiatry 77:714-718 (Pubitemid 43837193)
18. Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A 1993 Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43:250-260 (Pubitemid 23060253)
19. McKeith IG, Ballard CG, Perry RH, Ince PG, O'Brien JT, Neill D, Lowery K, Jaros E, Barber R, Thompson P, Swann A, Fairbairn AF, Perry EK 2000 Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology 54:1050-1058 (Pubitemid 30151844)
20. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF 1998 Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51:1546-1554
21. Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B 2007 Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 22:1689-1707; quiz 1837
22. Juul A, Flyvbjerg A, Frystyk J, Müller J, Skakkebaek NE 1996 Serum concentrations of free and total insulin-like growth factor-I, IGF binding proteins-1 and -3 and IGFBP-3 protease activity in boys with normal or precocious puberty. Clin Endocrinol (Oxf) 44:515-523
23. Miller SA, Dykes DD, Polesky HF 1988 A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
24. Berrigan D, Potischman N, Dodd KW, Hursting SD, Lavigne J, Barrett JC, Ballard-Barbash R 2009 Race/ethnic variation in serum levels of IGF-I and IGFBP-3 in US adults. Growth Horm IGF Res 19:146-155
25. Kalmijn S, Janssen JA, Pols HA, Lamberts SW, Breteler MM 2000 A prospective study on circulating insulin-like growth factor I (IGF-I), IGF-binding proteins, and cognitive function in the elderly. J Clin Endocrinol Metab 85:4551-4555 (Pubitemid 32157632)
26. Landi F, Capoluongo E, Russo A, Onder G, Cesari M, Lulli P, Minucci A, Pahor M, Zuppi C, Bernabei R 2007 Free insulin-like growth factor-I and cognitive function in older persons living in community. Growth Horm IGF Res 17:58-66
27. Mustafa A, Lannfelt L, Lilius L, Islam A, Winblad B, Adem A 1999 Decreased plasma insulin-like growth factor-I level in familial Alzheimer's disease patients carrying the Swedish APP 670/671 mutation. Dement Geriatr Cogn Disord 10:446-451 (Pubitemid 29512010)
28. Murialdo G, Barreca A, Nobili F, Rollero A, Timossi G, Gianelli MV, Copello F, Rodriguez G, Polleri A 2001 Relationships between cortisol, dehydroepiandrosterone sulphate and insulin-like growth factor-I system in dementia. J Endocrinol Invest 24:139-146 (Pubitemid 32293635)
29. Phillips MB, Foley AL, Barnard R, Isenring EA, Miller MD 2010 Nutritional screening in community-dwelling older adults: a systematic literature review. Asia Pac J Clin Nutr 19:440-449
30. Ketelslegers JM, Maiter D, Maes M, Underwood LE, Thissen JP 1996 Nutritional regulation of the growth hormone and insulin-like growth factor-binding proteins. Horm Res 45:252-257 (Pubitemid 26079718)
31. Friedrich N, Haring R, Nauck M, Lüdemann J, Rosskopf D, Spilcke-Liss E, Felix SB, Dörr M, Brabant G, Völzke H, Wallaschofski H 2009 Mortality and serum insulin-like growth factor (IGF)-I and IGF binding protein 3 concentrations. J Clin Endocrinol Metab 94:1732-1739
32. Friedrich N, Schneider H, Dörr M, Nauck M, Völzke H, Klotsche J, Sievers C, Pittrow D, Böhler S, Lehnert H, Pieper L, Wittchen HU, Wallaschofski H, Stalla GK 2011 All-cause mortality and serum insulin-like growth factor I in primary care patients. Growth Horm IGF Res 21:102-106
33. Deelen J, Beekman M, Uh HW, Helmer Q, Kuningas M, Christiansen L, Kremer D, van der Breggen R, Suchiman HE, Lakenberg N, van den Akker EB, Passtoors WM, Tiemeier H, van Heemst D, de Craen AJ, Rivadeneira F, de Geus EJ, Perola M, van der Ouderaa FJ, Gunn DA, Boomsma DI, Uitterlinden AG, Christensen K, van Duijn CM, Heijmans BT, Houwing-Duistermaat JJ, Westendorp RG, Slagboom PE 2011 Genome-wide association study identifies a single major locus contributing to survival into old age; the APOE locus revisited. Aging Cell 10:686-698
34. Okereke OI, Kang JH, Ma J, Gaziano JM, Grodstein F 2006 Midlife plasma insulin-like growth factor I and cognitive function in older men. J Clin Endocrinol Metab 91:4306-4312 (Pubitemid 44833403)
35. Okereke O, Kang JH, Ma J, Hankinson SE, Pollak MN, Grodstein F 2007 Plasma IGF-I levels and cognitive performance in older women. Neurobiol Aging 28:135-142 (Pubitemid 44791631)
36. Niikura T, Hashimoto Y, Okamoto T, Abe Y, Yasukawa T, Kawasumi M, Hiraki T, Kita Y, Terashita K, Kouyama K, Nishimoto I 2001 Insulin-like growth factor I (IGF- I) protects cells from apoptosis by Alzheimer's V642I mutant amyloid precursor protein through IGF-I receptor in an IGF-binding protein-sensitive manner. J Neurosci 21:1902-1910 (Pubitemid 32221374)
37. Carro E, Spuch C, Trejo JL, Antequera D, Torres-Aleman I 2005 Choroid plexus megalin is involved in neuroprotection by serum insulin-like growth factor I. J Neurosci 25:10884-10893 (Pubitemid 41692618)
38. Nishijima T, Piriz J, Duflot S, Fernandez AM, Gaitan G, Gomez-Pinedo U, Verdugo JM, Leroy F, Soya H, Nuñez A, Torres-Aleman I 2010 Neuronal activity drives localized blood-brain-barrier transport of serum insulin-like growth factor-I into the CNS. Neuron 67:834-846
39. Carro E, Trejo JL, Gerber A, Loetscher H, Torrado J, Metzger F, Torres-Aleman I 2006 Therapeutic actions of insulin-like growth factor I on APP/PS2 mice with severe brain amyloidosis. Neurobiol Aging 27:1250-1257 (Pubitemid 44088577)
40. Schubert M, Brazil DP, Burks DJ, Kushner JA, Ye J, Flint CL, Farhang-Fallah J, Dikkes P, Warot XM, Rio C, Corfas G, White MF 2003 Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation. J Neurosci 23:7084-7092 (Pubitemid 36975873)
41. Schubert M, Gautam D, Surjo D, Ueki K, Baudler S, Schubert D, Kondo T, Alber J, Galldiks N, Küstermann E, Arndt S, Jacobs AH, Krone W, Kahn CR, Brüning JC 2004 Role for neuronal insulin resistance in neurodegenerative diseases. Proc Natl Acad Sci USA 101:3100-3105 (Pubitemid 38327741)
42. Ricort JM, Binoux M 2001 Insulin-like growth factor (IGF) binding protein-3 inhibits type 1 IGF receptor activation independently of its IGF binding affinity. Endocrinology 142:108-113 (Pubitemid 32183671)
43. Ikonen M, Liu B, Hashimoto Y, Ma L, Lee KW, Niikura T, Nishimoto I, Cohen P 2003 Interaction between the Alzheimer's survival peptide humanin and insulin-like growth factor-binding protein 3 regulates cell survival and apoptosis. Proc Natl Acad Sci USA 100:13042-13047 (Pubitemid 37340022)
44. Hashimoto Y, Tsuji O, Niikura T, Yamagishi Y, Ishizaka M, Kawasumi M, Chiba T, Kanekura K, Yamada M, Tsukamoto E, Kouyama K, Terashita K, Aiso S, Lin A, Nishimoto I 2003 Involvement of c-Jun N-terminal kinase in amyloid precursor protein-mediated neuronal cell death. J Neurochem 84:864-877 (Pubitemid 36176943)
45. Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, Belleville S, Brodaty H, Bennett D, Chertkow H, Cummings JL, de Leon M, Feldman H, Ganguli M, Hampel H, Scheltens P, Tierney MC, Whitehouse P, Winblad B; International Psychogeriatric Association Expert Conference on mild cognitive impairment 2006 Mild cognitive impairment. Lancet 367:1262-1270
46. Frystyk J, Brick DJ, Gerweck AV, Utz AL, Miller KK 2009 Bioactive insulin-like growth factor-I in obesity. J Clin Endocrinol Metab 94:3093-3097
47. Obermayr RP, Mayerhofer L, Knechtelsdorfer M, Mersich N, Huber ER, Geyer G, Tragl KH 2005 The age-related down-regulation of the growth hormone/insulin-like growth factor-1 axis in the elderly male is reversed considerably by donepezil, a drug for Alzheimer's disease. Exp Gerontol 40:157-163 (Pubitemid 40343006)